Early trial aims to supercharge radiation for lung cancer
NCT ID NCT03824327
Summary
This early-stage study is testing whether adding a drug called papaverine to a precise form of radiation therapy makes the treatment more effective for patients with non-small cell lung cancer or lung tumors that have spread. The main goal is to find the safest dose of papaverine when given with radiation. Researchers will also check if special MRI scans or blood tests can predict which patients might benefit most from this combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.